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BACKGROUND: Little information is available on the official postgraduate and 
subspecialty training programs in movement disorders (MD) in Europe and North Africa.  
OBJECTIVE: To survey the accessible MD clinical training in these regions.  
METHODS: We designed a survey on clinical training in MD in different medical fields, at 
postgraduate and specialized levels. We assessed the characteristics of the participants and 
the facilities for MD care in their respective countries. We examined whether there are 
structured, or even accredited postgraduate, or subspecialty MD training programs in 
neurology, neurosurgery, internal medicine, geriatrics, neuroradiology, neuropediatrics, and 
general practice. Participants also shared their suggestions and needs. 
RESULTS: The survey was completed in 31/49 countries. Structured postgraduate MD 
programs in neurology exist in 20 countries; structured neurology subspecialty training exists 
in 14 countries and is being developed in two additional countries. Certified neurology 
subspecialty training was reported to exist in 7 countries. Recommended reading lists, printed 
books, and other materials are the most popular educational tools, while courses, lectures, 
webinars, and case presentations are the most popular learning formats. Mandatory activities 
and skills to be certified were not defined in 15/31 countries. Most participants expressed 
their need for a mandatory postgraduate MD program and for certified MD sub-specialization 
programs in neurology.    
CONCLUSIONS: Certified postgraduate and subspecialty training exists only in a minority 
of European countries and was not found in the surveyed Egypt and Tunisia. MD training 
should be improved in many countries.  




The topic of movement disorders (MD) is a fundamental part of neurology training in the 
gradual medical education and at the postgraduate level (training before neurology specialist 
certification) and even in the sub-specialization (becoming competent in a distinct practice 
area within neurology, after specialist certification). Certified MD subspecialty training 
programs exist in medical universities in the United States of America (USA) and Canada; 
however, they are not nationally standardized [1]. There is currently little information on the 
structure of postgraduate and subspecialty MD training in Europe and North Africa. An 
assessment of which countries have organized mandatory or optional programs at the 
different training levels, what their contents are, and how they relate to available facilities in 
the local MD centers is lacking. Thus, our main goal was to characterize the postgraduate and 
subspecialty MD training programs available throughout Europe and North Africa.  
 
Methods 
A survey was developed within the framework of the International Parkinson and Movement 
Disorder Society (MDS). This survey was sent to countries affiliated with the MDS-European 
Section [2] (Europe, North Africa, Russia, and Southwest Asia) in 2018. 
We assigned one MDS member from each country to complete the survey. Each participant 
was asked to provide educational information on a national level. We requested that they 
consult the appropriate personnel and colleagues, as needed, to provide reliable data. 
We selected participants from the MDS Young Members Group, the MDS Leadership 
Development and Training Program, and other members of the MDS. The survey consisted 
of four different parts (Supplement 1). We assessed the characteristics of the participants in 
Part I and of the country in Part II, with special emphasis on how medical care is established 
for MD and which invasive therapies are available. The number of MD centers, as well as of 
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MD specialists (working in tertiary referral MD centers) are estimations as their definition is 
not clarified in many countries. Part III surveyed whether there is structured or accredited 
postgraduate subspecialty MD training for the following medical fields: neurology, 
neurosurgery, internal medicine, geriatrics, neuroradiology, neuropediatrics, and general 
medical practice. Neurologists reported on these programs as MD is primarily a neurological 
topic, neurologists and neurological associations organize MD training also for other 
specialties. The length of training, the tools, and the highlighted topics were appraised in 
detail in each medical specialty. Necessary compliances for the neurology postgraduate and 
subspecialty trainings were further explored. When the participant reported on accredited 
training at each level the accrediting body was also provided. In Part IV, we asked the 
participants to give their opinions on how MD education could be developed further 
nationally, and what their needs were. Ethical approval was not required for this study 
because applied medical care and educational methods were analyzed. We used descriptive 
statistics for data presentation. We calculated the number of facilities/ 1 million inhabitants as 
relative numbers. We performed the Mann-Whitney rank-sum test to compare the number of 
facilities in countries with and without certified MD subspecialty training. The level of 
statistical significance was established at p<0.05.        
 
Results 
We sent surveys to 49 countries and received data from 31 of them (Fig 1). We did not 
receive answers from Algeria, Morocco, Albania, Belarus, Belgium, Bosnia and 
Herzegovina, Bulgaria, Cyprus, Greece, Iceland, Israel, Lithuania, Luxembourg, Macedonia, 
Russia, Seychelles, Slovenia, and the Ukraine. 
1. Part I 
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The age of participants was 42.4±10.10 years (mean±SD). They qualified as a medical doctor 
in an average of 16.7±9.60 years. All were neurologists and 90% were specialized. Seventy-
one percent had a Ph.D and all were involved in research activities. Seventy-one percent 
worked as movement disorder specialists; 35% also worked in general neurology; 3% had a 
resident assignment. Ninety-seven percent were employed in an academic/university hospital; 
13% had a position in private practice, and 6% in a state hospital.  
2. Part II 
Facilities for MD patient care are summarized in Table 1. In the surveyed countries, the 
median relative number of MD centers was 0.49 (IQR: 0.3-0.8). The highest relative number 
of MD centers was reported from Austria, Portugal, and Norway. The median relative 
number of neurologists was 71.2 (IQR: 38-102.4). The highest relative number of physicians 
considered to be experts in MD was found in Austria, Italy, and Estonia. The median number 
of MD experts in the countries was 1.53 (IQR: 0.8-3.77). Four countries did not have an MD 
society or section. The median relative number of deep brain stimulation (DBS) centers was 
0.28 (IQR: 0.01-0.49), while that of botulinum toxin (BTX) centers was 0.97 (IQR: 0.51-
1.83). DBS was available in 25 of the 31 countries and was started 18±5.91 (mean±SD) years 
ago. The highest relative numbers of DBS surgeries were reported from Norway, Finland, 
and The Netherlands. BTX was not available in one country.  
3. Part III 
Twenty countries (64%) had structured MD programs (seven optional, 13 mandatory) 
incorporated into the neurology postgraduate training program. Most courses lasted 1-3 
months. Accreditation of these courses was reported from nine countries, and Austria, 
Germany had certification for the postgraduate BTX training (Table 2).  
Responders from 14 countries (45%) reported structured MD programs for neurology 
specialists, most of which last for more than one year; but these programs are only certified in 
 9 
seven countries (HR, CZ, DK, FR, NL, RS, SE; Figure 1, Table 2). MD specialist training is 
currently under development in Poland and Switzerland. Austria, Germany, and The 
Netherlands have certified BTX training for neurologists.  
Regarding specialties other than neurology, the most structured MD program was reported 
for neurosurgeons and neuropediatricians (Table 2). Neuroradiology exists as a subspecialty 
in 14 countries (45%), and neuropediatrics in 20 countries (65%). Sweden and France have 
MD training available for most specialties (Sweden: neurology, neurosurgery, geriatrics and 
neuroradiology; France: neurology, neurosurgery, and neuropediatrics) (Table 2). In The 
Netherlands, ParkinsonNet actively provides Parkinson training to neurologists and allied 
health professionals with specific recognitions [3].  
There was no difference in the relative number of MD experts, MD centers, DBS centers, 
DBS implantations in 2017, and BTX centers between countries that do and do not have 
certified MD sub-specialization (Table 3). Neurology training in most countries covered the 
following main topics: Parkinson’s disease (PD), atypical Parkinsonism, chorea, dystonia, 
and tremor (Table 4). In most countries, the MD program for neurosurgeons focuses on DBS 
indications (PD, dystonia, and tremor) in addition to the basic neuroscience of MDs and 
functional neurosurgery (including DBS). Various MD topics are covered by other 
specialties.   
In order to fulfill the postgraduate MD program, five countries require a minimum number of 
MD patients examined in the hospital and outpatient clinic, and treated by BTX and advanced 
therapies. It is a requirement for subspecialty training in four countries (Table 5). No country 
requires a specific number of first and follow-up visits. Training in application of clinical 
scales and neuropathology are parts of the postgraduate neurology curriculum in most 
reporting countries. Courses on using clinical scales, jejunal levodopa pump and BTX 
therapy are offered to neurology specialists in most countries. Teaching is an expectation of 
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MD subspecialty training in five countries, research in eight countries, and performing 
presentations in MD conferences in nine countries (Table 5).  
Regarding learning materials, recommended readings and printed books/materials are the 
most popular, both for postgraduate and subspecialty MD training (Fig 2). This material is 
often free for all or free for program participants, and members of the national MD section, or 
access can be bought. The most popular educational activities are courses/lectures/webinars 
or case presentations with experienced tutors.      
4. Part IV 
 Most responders are of the opinion that there is a need for a mandatory postgraduate MD 
program with a longer duration (more than one month) and an extended curriculum for 
neurologists. They would like to have a certified MD specialty in their countries. Optional 
MD training was also suggested for specialties other than neurology, supporting the concept 
of interdisciplinary care for MDs. Responders are of the opinion that the requirements for an 
MD center should be defined. Rotation between MD centers and more fellowship 
opportunities to MD centers abroad could be beneficial; one responder considered that it 
should be mandatory for a MD Specialist Certification. In many countries there is a need for 
regular comprehensive MD courses with invited speakers. There was a suggestion that access 
to video education material with interpretation would be helpful for local educational 
activities.    
 
Discussion 
The results of our survey highlight that certified postgraduate and subspecialty MD training 
exists only in a minority of the surveyed countries.  
Indeed, we found that the postgraduate education for MDs is not well structured in most 
countries. MD sub-specialization is available in 14/31 (45%) countries for neurologists; it is 
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accredited in only 7/31 (22%) countries and is under development in two additional 
countries. 
In the 1990s, following the rapid scientific and therapeutic advancements that were taking 
place in the field, traditional training in general neurology required sub-specialization [4,5]. It 
is still a matter of debate as to whether sub-specializations have a positive or negative impact 
on patient care or on the professional motivation of physicians. All in all, it is still a principle 
that sub-specializations should be built on the knowledge of general neurology in order for 
the appropriate clinical diagnosis and proper care to be provided [6]. Sub-specialization is 
beneficial in many aspects. The health care environment in many countries favors the 
accountability of physicians with a high patient volume, and therefore, proficiency in skills 
[5]. It has been demonstrated that the diagnosis of Parkinson’s disease (PD) is more accurate 
in a movement disorder clinic [7] than in a general neurological practice [8]. Moreover, 
specialists are better able to manage non-motor and motor complications in PD than general 
neurologists [9]. In 1997, the European Parkinson’s Disease Association and the World 
Health Organization declared that PD patients want the right to be referred to a doctor with a 
special interest in PD [10].  
The optimal position of MD experts should be found in patient care networks; their role 
should at least be in initial diagnosis and infrequent follow-ups [11], depending on the 
applied therapy and general needs of the country.  
In the USA, many universities have announced MD fellowship training [1]. These fellowship 
programs are often flexible; the participants can visit multiple training centers with the 
assistance of the San Francisco residency and fellowship match services supervised by an 
expert committee [12]. This program is not consistent with others in the region as it is not 
endorsed by the two main certifying bodies, the Accreditation Council for Graduate Medical 
Education (ACGME) or the United Council for Neurologic Subspecialties (UCNS) [13]. The 
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program is instead certified by the Institutional Graduate Medical Office (GME) and the State 
Medical Board. The UCNS was initiated by the American Academy of Neurology in 2001 for 
the USA and Canada to provide accreditation and certification of neurological subspecialty 
fellowship programs [4]. However, it has identified nine subspecialties until now, not 
including the recognition of MD for which no application has been made.  
In Europe, Egypt and Tunisia, we have found that MD subspecialty training does not exist or 
is not accredited in most countries, even though MD is the most popular field among 
European neurology residents and is often a future sub-specialization for young neurologists 
[14]. 
The existing certified programs have not yet had an impact on the number of MD experts and 
facilities of care in the different countries, maybe because of their short history.  
Twenty-two countries have had DBS for more than 10 years and there is no certified 
subspecialty MD training in 16 of them (Table 1). Training for invasive therapies such as 
BTX, DBS, and jejunal levodopa pump are principally set up by the respective companies 
without any agreement between them and countries regarding curriculum and eligibility 
requirements. The MDS also offers optional and international courses in these topics.  
We explored that conventional educational tools and activities are widely used instead of 
internet-based educational materials, which would better support the contemporary 
educational formats including the flipped classroom approach and interactive, social learning 
[15].   
The limitations of our study are that we did not get an answer from 36,7% of the countries, 
and we asked one clinician from each country. However, the participants from 30/31 
countries were employed in a university, and they were all MDS members. They consulted 
with relevant colleagues in universities, societies, agencies, offices, companies, and took full 
responsibility for the declared numbers and answers.   
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According to our results, the term movement disorders specialist and movement disorders 
center is unofficially defined in most of the countries. Many countries wish to improve their 
teaching methods for MD, which would be beneficial in the quality assurance of clinical care.  
The structure of education programs and a curriculum (the optimal duration of the training, 
educational formats, and the certifying body) could be implemented in each country 
according to local authority requirements. MDS could support these initiatives with a core 
curriculum. MD rotations could offer the opportunity to visit experienced MD centers and 
study the diagnostics and management of patients with a complex MD, as well as advanced 
therapies. Early identification of trainees interested in MD would be beneficial. Roles for MD 
specialists and licensing requirements of an MD center should be determined. Setting up a 
structured network with tertiary, highly specialized hospitals would promote the care of 
difficult MD cases. The opinions about the need for certification are controversial; 
nevertheless, it is an educational tool, which guarantees a standard in medical training and 
quality in medical care. Local laws should determine the way of certification in each country, 
in which an MDS-ES exam could optionally count. 
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Table 1. Country characteristics, facilities for the care of movement disorders 



























No. of MD 
experts/ neuro-
logists (per 1 
million people; 
estimation) 
Armenia (AM) 2.930 1/0/2 - 0 1 4 0.68/102.39 
Austria (AT) 8.735 32/5/15 1999 40 1 5 13.74/129.13 
Azerbaijan (AZ) 9.827 3/0/10 - 0 1 2 1.02/71.23 
Croatia (HR) 4.189 3/1/4 1995 12 1 4 4.77/83.55 
Czech Republic (CZ) 10.618 3/3/29 1998 50 1 8 2.35/84.76 
Denmark (DK) 5.778 14/2/9 1997 50 1 4 5.19/46.73 
Egypt (EG) 97.553 8/1/7 2001 6 2 25 1.54/20.5 
Estonia (EE) 1.309 2/1/5 2006 4 1 1 7.64/109.24 
Finland (FI) 5.523 5/5/25 1995 110 1 5 3.62/78.4 
France (FR) 64.979 25/20/50 1986 400 4 37 3.08/38.01 
Georgia (GE) 3.912 2/1/2 ≈ 
2020 
0 1 5 1.28/187.88 
Germany (DE) 82.114 24/40/250 2000 700 25 24 NA/121.78 
Hungary (HU) 9.721 4/5/7 1998 120 2 4 2.57/88.67 
Ireland (IE) 4.761 7/1/5 2009 0 0 6 1.05/7,56 
Italy (IT) 59.359 30/29/60 1996 280 1 40 8.81/109.05 
Latvia (LV) 1.949 0/0/1 2005 0 1 2 1.03/145.2 
Montenegro (ME) 0.628 0/0/1 - 0 0 1 NA/44.59 
The Netherlands 
(NL) 
17.035 10/6/50 1993 250 1 8 1.76/46.96 
Norway (NO) 5.305 15 (1 formal) 
/2/20 
1995 110 1 4 3.77/87.84 
Poland (PL) 38.170 15 adult+3 
children/18/7
0 
1999 334 2 21 NA/112.7 
Portugal (PT) 10.329 32/6/›10 2002 30 1 6 5.03/34.95 
Republic of 
Moldova (MD) 
4.051 1/0/0 - 0 0 1 1.23/74.06 
Romania (RO) 19.679 8/2/6 2004 6 0 12 NA/40.65 
Republic of Serbia 
(RS) 
8.790 4/0/3 - 0 1 6 0.8/51.19 
Slovak Republic 
(SK) 
5.447 4/3/17 2002 30 1 3 1.84/91.79 
Spain (ES) 46.354 8/8/ND 1998 ND 17 47 NA/34.67 
Sweden (SE) 9.910 7/6/6 1993 60 2 7 3.53/32.29 
Switzerland (CH) 8.476 7/4/7 1998 100 1 6 4.72/70.79 
Tunisia (TN) 11.532 2/0/3 2006 0 1 4 0.35/18.04 
Turkey (TR) 80.745 40/15/60 1999 572 2 84 0.93/61.92 
United Kingdom 
(UK) 
66.181 50/16/89 1997 300 2 36 1.51/13.67 
 http://worldpopulationreview.com/countries/; MD: movement disorder; DBS: deep brain stimulation; BTX: botulinum toxin; ND: 
no data; N: no; Y: yes 
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Table 2. Structured movement disorder programs at postgraduate and specialized levels in 
different specialties as reported by the different countries. Official accreditation is listed if it 
exists  
Specialty/ 
level of training 
Structured MD program 
exists 
Duration (Month) Accrediting body 
Neurology/ 
Postgraduate 
Optional: AM, AT , DE , 
GE, IT, NL, SE, CH, PT  
Mandatory: AM, AZ, 
HR, EG, FR, GE, HU, 
IE, ME, MD, ES, TR, 
UK 
≤1: GE, HU, SE 
1-3: AM, AZ, 
HR, EG, IT, ME, 
MD, ES 
3-6: FR, PT, TR 
6-12: IE, NL   
AM: Ministry of 
Education and 
Science, AT : c,d; 
HR: a, FR: e, GE: 
a, DE: d , IE: a; 
ME: b,e; MD: a, 
NL: e; SE: b 
Neurology/ 
Subspecialty 
AT , AZ, HR, CZ, DK, 
EG, ES, FR, DE , NL, 
PT, RS, SE, SK, TR, UK 
≤1: AZ, EG, SE 
3-6: HR 
6-12: RS, FR 
>12: CZ, DK, ES, 
NL, SK, TR, UK 
HR: a, CZ: d, DK: 
d, FR: e, DE: d , 
NL: c,d; RS: b,c,e; 
SE: Scandinavian 
MD Society    
Neurosurgery/ 
Postgraduate 
Optional: AZ, EG, ME, 
ES, SE, CH, TR, UK 
Mandatory: HR, HU 
≤1: AZ, EG, HU, 
SE 
ME: b,e; SE: b 
Neurosurgery/ 
Subspecialty 
AZ, EG, ES, FR, HU, 
SE, TR, UK 
≤1: AZ, EG, SE  
1-3: HU, TR   
6-12: FR  
>12: ES, UK 





Mandatory: CH, HR, IE  1-3: IE IE: a  
Internal Medicine/ 
Subspecialty 
- - - 
General practitioner/ 
Postgraduate 
Mandatory: HR   
General practitioner/ 
Subspecialty 
- - - 
Geriatrician/ 
Postgraduate 
Mandatory: EG, IE, UK 




IE: a, SE: b 
Geriatrician/ 
Subspecialty 
SE, TR ≤1: SE 
1-3: TR 
SE: Scandinavian 
MD Society  
Neuroradiologist/ 
Postgraduate 





EG, SE ≤1: SE 
 
SE: Scandinavian 
MD Society  
Neuropediatrician/ 
Postgraduate 
Mandatory: AM, EG, 
ME, RS, UK  
Optional: PT, TR, IT  
≤1: EG 
1-3: PT, IT 
 ME: b, e 
Neuropediatrician/ 
Subspecialty 
EG, ES, FR, IE, TR, UK ≤1: EG, UK  
1-3: IE, 
FR: e, IE: a 
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3-6: TR, 
6-12: FR  
>12: ES 
  only for Botulinum toxin; a: National Board of Medical Specialties/General Medical Council independent from the government, b: 
General Medical Board/Council belonging to the Ministry of Health; c: National Neurological Society; d: National Movement Disorders 























Table 3. Relationship of the resources in patient care and the existence of certified movement 
disorder training  
Relative number Median (inter-quartile range) 
Certified/non-certified training 
Difference between countries 




3.08 (1.76-4.77)/ 1.25 (0.51-
3.69) 
U=55; Z=1.37; p=0.17 
MD centers 0.58 (0.38-0.72)/ 0.48 (0.27-
0.86) 
U=76; Z=0.35; p=0.73 
DBS centers 
 
0.31 (0.24-0.35)/ 0.24 (0-0.5) U=80; Z=0.19; p=0.85 
BTX centers 
 
0.95 (0.6-2.73)/ 0.99 (0.51-
1.77) 
U=81; Z=0.14; p=0.89 
DBS implants in 2017 
 


















Table 4. The highlighted topics of movement disorder training in the seven specialties at 
postgraduate and specialized educational levels 




NS I GP G NR NP  
Parkinson’s disease  14/11 5/7 1/0  4/3  1/3 
Atypical Parkinsonism  14/10 1/2 1/0  3/2  0/4 
Chorea  13/10 2/4 1/0  2/2  1/4 
Dystonia  12/10 4/6 1/0  2/2  1/4 
Ataxia  11/9 1/2 1/0  2/2  1/4 
Tremor  10/10 2/5 1/0  2/2  1/4 
Tics and Tourette syndrome  10/9 1/3 1/0  2/2  0/4 
Huntington’s disease  10/9 1/2 1/0  2/1  0/3 
Basic neuroscience of movement disorders  8/9 2/6 1/0  1/1  1/4 
Myoclonus  10/7 1/2 1/0  2/1  1/4 
Psychogenic movement disorders  7/9 0/2 1/0  1/1  1/4 
Gait disorders  9/7 2/4 1/0  2/2  1/3 
Cognitive impairment in PD 8/8 1/2   2/2  0/1 
Botulinum toxin treatment of movement 
disorders  
6/9 1/2 1/0  2/1  0/1 
Genetics of movement disorders  7/8 1/2   1/1  1/4 
Autonomic dysfunction  8/7 1/2   1/2  1/1 
Movement disorder emergencies  7/7 0/2 1/0  1/1  1/2 
Sleep disorders  8/6 1/2 1/0  2/1  1/2 
Wilson’s disease  8/7 0/1   0/1  1/3 
Psychiatric disturbances in movement disorders  7/8 1/2   1/1  0/1 
Restless leg syndrome  8/7 1/1   1/1  1/0 
Neuroimaging  8/6 1/3 1/0  2/0 1/0 1/3 
Paroxysmal movement disorders PG 7/7 0/1 1/0  1/0  1/3 
Invasive therapies in PD 5/7 2/4   2/1  0/1 
Neurobehavioral complications in PD 6/6 1/2 0/0  2/2  0/1 
Functional neurosurgery (including DBS)  3/8 3/6   0/1  0/2 
Spasticity  6/5 1/4 1/0  1/1  1/3 
Non-pharmacological therapies in PD 5/6 2/3   2/1  0/1 
Neuropharmacology  5/5 0/2 1/0  2/1  1/2 
Clinical neurophysiology  4/5 1/2 1/0  1/0  1/1 
Eye movement abnormalities in movement 
disorders  
5/4 0/1 1/0  1/0  0/3 
Pediatric movement disorders  4/4 0/1     1/3 
Evidence-based medicine in movement 
disorders  
4/4 1/2 1/0  2/0  1/2 
Movement disorders and Internal Medicine  4/4  2/0  1/1  0/1 
Rehabilitation in movement disorders PG 1/6  1/0  1/0  1/1 
Neuropathology  2/3 0/1 1/0  1/1  1/0 
E-Health and movement disorders 0/1       
PG: postgraduate education; S: sub-specialization; N: Neurology; NS: Neurosurgery; I: Internal Medicine; GP: General practitioner; G: 
Geriatrician; NR: Neuroradiologist; NP: Neuropediatrician 
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Table 5. The required compliances in the neurology postgraduate and subspecialty training 
Required compliances in 
Neurology 
Postgraduate MD Sub-specialization 
Patient number in an 
outpatient clinic 
100HR, 50(in+out)HU  150HR, 20FR, 
100(in+out+children)NL 
Patient number in the 
inpatient care 
50AZ, 30HR 60HR 
No of BTX cases 10HR, 75DE 30HR, 20FR, 75DE 
Patient selection for DBS     
Patient selection for other 
advanced therapies in PD  
10HR 20HR 
Basic DBS course  CZ, DK, FR, NL, SE 
Intraoperative testing for 
DBS 
 NL 
Basic course on jejunal 
levodopa pump therapy  
HR, SE HR, CZ, DK, NL, RS, SE 
Basic course on apomorfin 
pump therapy  
SE HR, DK, NL, RS, SE 
Basic course on BTX 
injection therapy 
IE HR, CZ, DK, FR, NL, RS, 
SE 
Application of clinical 
scales 
AZ, HR, IE, MD, SE AZ, HR, CZ, NL, RS, SE 
Neurophysiological 
assessment of movement 
disorders 
AZ, IE, MD AZ, HR, CZ, NL, RS 
Neuropathology AZ, HU, IE, MD AZ, HR, DK, NL 
Assistance in clinical 
studies 
HR HR, NL, RS, TR 
Required patient number 
for first examination 
- 
 
Required patient number 
for follow-up visit?  
- 
 
Teaching - AZ, HR, FR, RS, TR, UK 
Research  
- 
EG, IT, NL, MD, RS, SE, 
TR, UK 





AZ, HR, CZ, IT, NL, MD, 
RS, TR, UK 








Map of the participating countries. Mid and dark grey colors indicate the participating 
countries. Countries in dark grey have certified movement disorder subspecialty training for 
neurologists. In each country, the estimated number of MD centers/MD experts are indicated. 
The figure is produced by Cartographia Tankönyvkiadó Kft 
Figure 2 
The educational materials and activities used in postgraduate and subspecialty training 
programs  
 
 
 
 
 
 
 
 
 
 
 
 
